Peptide Half-Life Explained: What It Means and What to Track

If you have ever read the label for a weekly GLP-1 or browsed research on peptides, you have probably seen the term half-life. It sounds technical, but the idea is simple. Once you understand it, a lot of things about timing start to make sense: why some injections are weekly and others are more frequent, why changes can take weeks to settle, and why a clean dose record matters so much when you talk with your provider.

This guide explains peptide half-life in plain language, shows a worked illustration, and covers what is worth keeping in your peptide tracker app so the timeline is never a guess.

What half-life actually means

A half-life is the time it takes for the amount of a drug in the blood to drop by half.

That is all it is. If a medicine has a half-life of one day, then one day after a dose, about half of it is still in the blood. After another day, about a quarter is left. After a third day, about an eighth.

The key point is that the drop happens in halves, not in a straight line. A drug does not disappear all at once when a "duration" runs out. It fades gradually, and each half-life removes half of whatever is left.

Why "4 to 5 half-lives" comes up so often

Pharmacology teaching material uses a handy rule of thumb. A review called Pharmacokinetics 101 in Paediatrics and Child Health explains it step by step. After one half-life, about 50 percent of a single dose remains. After two, about 25 percent. By four to five half-lives, roughly 94 to 97 percent of that dose is gone.

The same review explains the flip side. When a drug is given repeatedly at a regular interval, levels build up over time. Around four to five half-lives after the first dose, the amount going in during each interval roughly matches the amount leaving. That balance is called steady state.

Why half-life matters for peptides and GLP-1s

Different peptides have very different half-lives. Some are cleared quickly. Others are designed to last.

The FDA prescribing information for two common GLP-1 medicines gives a clear example:

• The Wegovy (semaglutide) label on DailyMed describes the half-life of semaglutide as approximately 1 week.
• The Mounjaro (tirzepatide) label on DailyMed describes an elimination half-life of approximately 5 days, and notes that this is what enables once-weekly dosing.

Both labels explain that these molecules bind to albumin, a protein in the blood, which slows how quickly they are cleared. That design choice is a big reason they last so much longer than many other peptides.

Research peptides that are not approved medicines often have far less published data on half-life in people. When the data is thin, it is worth being honest about that and leaning on your provider rather than on online claims.

A worked illustration of the numbers

The example below is only an illustration of how the arithmetic works. It is not guidance on what anyone should take or when.

Imagine a medicine with a half-life of about one week, given on a regular weekly schedule set by a provider.

1. One week after the first dose, about half of that first dose is still in the blood.
2. The second dose is added on top of what remains, so the level is higher than after the first dose.
3. Each week the level climbs a bit more, but by a smaller step each time.
4. After roughly four to five weeks (four to five half-lives), the amount added each week and the amount cleared each week come close to balancing out. That is steady state.

Two practical ideas fall out of this.

First, when a provider changes a dose of a long half-life medicine, the body does not reach its new steady level the next day. It takes several half-lives. That is one reason providers often talk about giving a step a few weeks before judging it.

Second, after stopping, a long half-life medicine also fades over weeks, not days. The Wegovy label reflects this directly. It advises stopping at least 2 months before a planned pregnancy "because of the long half-life of semaglutide."

What half-life does not tell you

Half-life is useful, but it is easy to read too much into it.

• It is an average. Labels report population values. Your own clearance can differ based on body size, kidney function and other factors your provider can assess.
• It is not the same as how long you feel an effect. Blood levels and how someone feels do not always move together.
• It does not set your schedule. Dose timing comes from your provider and the product's prescribing information, not from doing math on a half-life yourself.
• It does not answer missed-dose questions. Both the Wegovy and Mounjaro labels have their own specific missed-dose instructions, and they are not the same. If you miss a dose, check with your provider or pharmacist about what to do for your medicine.

What to track so the timeline is clear

Because long half-life medicines build up and fade slowly, the story often only makes sense when you look back over several weeks. Memory is not great at that. A simple, consistent record is.

The dose itself

Log every dose with the date, the time and the amount your provider gave you. Note whether it was on schedule, late, or missed. A dose history that shows weeks at a glance makes the build-up and fade-out periods easy to line up with everything else.

Changes and when they happened

Write down the exact date of any change your provider makes. Mark the start of each new step in a titration schedule so you can count how many weeks you have actually been on it. With a long half-life, "I changed it last Tuesday" and "I changed it a month ago" are very different situations.

Vial details for mixed peptides

If you use a peptide that you mix from powder, record the vial strength, the water added and the date it was mixed. Getting the units right matters before anything else. Peppy's free peptide calculator works out the concentration, the volume and the units on a U-100 syringe from the vial strength, the water you added and the dose your provider gave you. It only converts numbers, so it never suggests a dose.

How you feel, in context

Note side effects and their severity, plus weight if that is part of your plan. Over time, you and your provider can see whether changes in how you feel line up with a recent dose change, a missed week, or something unrelated. The weight, side effects and history help page covers how these check-ins can sit next to your doses.

Keeping the record in Peppy

Peppy is a peptide tracker app for iPhone that keeps this whole timeline in one place. You enter the vial and the dose your provider gave you, log each dose, and get a reminder when each dose is due. Logged and missed doses show up on a calendar with your on-time percentage, which is exactly the kind of history that makes half-life conversations easier.

If you are on semaglutide or tirzepatide, the GLP-1 tracker page has more on keeping these records for weekly injections. Everything stays on your iPhone and your own iCloud backup, with no account needed.

Bringing it to your appointment

When you meet your provider, a few questions tied to your record can make the visit more useful:

• How long should I expect before a change settles in, given this medicine's half-life?
• What should I do if I miss a dose of this specific product?
• Is there anything about my own health that could change how quickly it is cleared?

Bring your dose history, the dates of every change, and your side-effect notes. With a clear record, half-life stops being an abstract number on a label and becomes a practical way to understand your own timeline.